Indian CRAMS Industry - For Indian Customers

Jun, 2013   |   Care Research   |   Format : PDF

Foreign Customers kindly click here

The Indian Contract Research and Manufacturing Services (CRAMS) industry is estimated to be worth ~US$6.6bn in CY2012. CRAMS industry has two main segments Contract Manufacturing Services (CMS), which accounts for more than 60% of the industry; and Contract Research Services (CRS), which accounts for the rest. CMS is expected to dominate the industry in the foreseeable future. CARE Research expects the domestic CRAMS industry to grow at robust rate from CY2013-2017.

Companies in the Indian CRAMS industry are benefitted by lower manufacturing costs, rising cost of research in developed markets and increase in number of drugs going off-patent. These conditions are leading to an increase in outsourcing of pharmaceutical manufacture and research. Indian companies are increasingly being preferred due to their product mix catering to high-end research services, biologics and complex technology services. Also, India offers a significant pool of professionals in the area of drug development and research chemistry with large number of pharmacists and chemistry post graduates qualifying every year.

The report on Indian CRAMS Industry evaluates the industry scenario and presents its outlook based on past performance and the evolving dynamic in the industry. It also focuses on growth opportunities, growth drivers, player analysis, and regulatory scenario. The report highlights various supportive measures taken by the government, that have helped the sector perform well.

The report also describes the global CRAMS industry scenario and analyses the major players, and competition. The report explains the challenges and risks faced by the industry players. The informative report is comprehensive and indispensable for any company in CRAMS industry, pharmaceuticals business, banks/ FIs, policy makers, research & academic organizations, other international and national agencies, etc. Additionally, the quarterly updates (for the period Q1FY14 to Q4FY14) accompanying the subscription of the said report would form a potent tool for the subscribers to keep abreast of the happenings in the industry.

SECTION- I CARE Researchs OUTLOOK 
Outlook 
Outlook on the Indian CRAMS Industry

SECTION- II INDUSTRY SECTION
Overview of Indian Pharmaceutical Industry
Major market segments 
Market size
Leading pharmaceutical companies in India 

Overview of Indian CRAMS Industry
Overview
Drug Life Cycle Process
Rise of CMOs
Rise of CROs
Outsourcing Trend
Factors responsible for outsourcing
Key ingredients for success in CRAMS space

Domestic CRAMS Drivers
Factors stimulating CRAMS
Regulatory Process
Governments initiatives
Indian Export Market

Global CRAMS Industry 
Overview of Global CRAMS Industry
Industry Practice Framework
Competition
Competitive landscape
Challenges and Risks

SECTION- III COMPANY SECTION
Biocon Ltd. 
Background
Collaboration
Annual Performance
Financial snapshot
Shareholding pattern
Stock price performance
Credit Rating

Jubilant Life Sciences Ltd.
Background
Collaboration
Annual Performance
Financial snapshot
Shareholding pattern
Stock price performance
Credit Rating

Shasun Pharmaceuticals Ltd.
Background
Collaboration
Annual Performance
Financial snapshot
Shareholding pattern
Stock price performance
Credit Rating

Piramal Healthcare Ltd.
Background
Collaboration
Annual Performance
Financial snapshot
Shareholding pattern
Stock price performance
Credit Rating

Dishman Pharmaceuticals and Chemicals Ltd.
Background
Collaboration
Annual Performance
Financial snapshot
Shareholding pattern
Stock price performance
Credit Rating

Divis Laboratories Ltd.
Background
Annual Performance
Financial snapshot
Shareholding pattern
Stock price performance
Credit Rating

List of Graphs and Tables

SECTION- I CARE Researchs OUTLOOK 

Outlook of Indian CRAMS Industry
Indian CRAMS Industry Market Size (CY10-17P)
Indian CMS Industry Market Size (CY10-17P)
Indian CRS Industry Market Size (CY10-17P)

SECTION- II INDUSTRY SECTION
Overview of Indian Pharmaceutical Industry
Major market segments
Indian Pharmaceutical Industry market size
Domestic Consumption market size
Top 10 Pharmaceutical companies in India 

Overview of Indian CRAMS Industry
Value Chain analysis
Drug life cycle process
Pharma outsourcing trend
Factors responsible for outsourcing
Healthcare as a percentage of GDP

Domestic CRAMS drivers
DMF Filings: World v/s India 
ANDA Final Approvals: World v/s India 
Country-wise Indian Pharmaceutical exports

Global CRAMS Industry
Global CRAMS industry
Lonza: Company Financials
Parexel International: Company Financials
Covance Inc: Company Financials
Patheon Inc: Company Financials
Icon Plc: Company Financials

SECTION- III COMPANY SECTION
Biocon Ltd. 
Increase in R&D investment 
Financial snapshot
EBITDA margin
Increasing raw material cost and employee expenses
Shareholding pattern
Increasing FII shareholding
Stock price performance
Credit rating

Jubilant Life Sciences Ltd.
Financial snapshot
EBITDA margin
Operating cost break-up
Shareholding pattern
Stock price performance
Credit rating

Shasun Pharmaceutical Ltd.
Financial snapshot
EBITDA margin
Operating cost break-up
Shareholding pattern
Stock price performance
Credit rating

Piramal Healthcare Ltd.
Financial snapshot
EBITDA margin
Operating cost break-up
Shareholding pattern
Stock price performance
Credit rating

Dishman Pharmaceutical and Chemicals Ltd.
Financial snapshot
EBITDA margin
Operating cost break-up
Shareholding pattern
Stock price performance
Credit rating

Divis Laboratories Ltd.
Financial snapshot
EBITDA margin
Operating cost break-up
Shareholding pattern
Stock price performance
Credit rating

Select a Licence type

Custom Research

We are known to provide exact requirements. Try our CUSTOM RESEARCH option and get the exact search result you are searching for.

Contact Us

Postal Address:
808, Real Tech Park, 8th Floor, Sector - 30A, Vashi, Navi Mumbai - 400703 , INDIA .
Telephone: +91 22 27810772, 27810773
Email: info@marketreportsonindia.com
Fax Number: +91 22 27812707

Follow Us On: